Synthesis, Gastroprotective Effect and Cytotoxicity of New Amino Acid Diterpene Monoamides and Diamides
作者:Guillermo Schmeda-Hirschmann、Mariano Walter Pertino、Jaime A. Rodriguez、Francisco Monsalve、Daniel Droguett、Cristina Theoduloz
DOI:10.3390/molecules15107378
日期:——
Following our studies on the gastroprotective effect and cytotoxicity of terpene derivatives, new amides were prepared from the diterpene 8(17)-labden-15,19-dioic acid (junicedric acid) and its 8(9)-en isomer with C-protected amino acids (amino acid esters). The new compounds were evaluated for their gastroprotective effect in the ethanol/HCl-induced gastric lesions model in mice, as well as for cytotoxicity using the following human cell lines: normal lung fibroblasts (MRC-5), gastric adenocarcinoma cells (AGS) and liver hepatocellular carcinoma (Hep G2). A dose-response experiment showed that at 25 mg/kg the C-15 leucyl and C-15,19-dileucylester amides of junicedric acid reduced gastric lesions by about 65.6 and 49.6%, respectively, with an effect comparable to lansoprazole at 20 mg/kg (79.3% lesion reduction). The comparison of the gastroprotective effect of 18 new amino acid ester amides was carried out at a single oral dose of 25 mg/kg. Several compounds presented a strong gastroprotective effect, reducing gastric lesions in the 70.9-87.8% range. The diprolyl derivative of junicedric acid, the most active product of this study (87.8% lesion reduction at 25 mg/kg) presented a cytotoxicity value comparable with that of the reference compound lansoprazole. The structure-activity relationships are discussed.
在对萜烯衍生物的胃保护作用和细胞毒性进行研究之后,我们利用二萜 8(17)-labden-15,19-dioic acid(朱尼地酸)及其 8(9)-en 异构体与 C 保护氨基酸(氨基酸酯)制备了新的酰胺。在乙醇/HCl 诱导的小鼠胃损伤模型中,对这些新化合物的胃保护作用进行了评估,并使用以下人体细胞系对其细胞毒性进行了评估:正常肺成纤维细胞(MRC-5)、胃腺癌细胞(AGS)和肝脏肝细胞癌(Hep G2)。剂量反应实验显示,在 25 毫克/千克的剂量下,朱尼地酸的 C-15 白基和 C-15,19-二异丁基酰胺可分别减少约 65.6% 和 49.6% 的胃部病变,其效果与 20 毫克/千克的兰索拉唑相当(病变减少 79.3%)。在单次口服剂量为 25 毫克/千克时,对 18 种新的氨基酸酯酰胺的胃保护作用进行了比较。有几种化合物具有很强的胃保护作用,可使胃部病变减少 70.9%-87.8%。朱尼地酸的二甘醇衍生物是本研究中最活跃的产品(25 毫克/千克的剂量可减少 87.8% 的病变),其细胞毒性值与参考化合物兰索拉唑相当。本文讨论了结构-活性关系。